Related Experiment Video
Updated: May 12, 2026
10:08
The Evoked Potential Operant Conditioning System (EPOCS): A Research Tool and an Emerging Therapy for Chronic Neuromuscular Disorders
Published on: August 25, 2022
ECOPA: the European Consensus Platform on Three Rs Alternatives
1Department of Toxicology, Vrije Universiteit Brussel, Laarbeeklaan 103, 1090 Brussels, Belgium. vrogiers@fafy.vub.ac.be
Alternatives to Laboratory Animals : ATLA
|April 13, 2013
Summary
The European Consensus Platform on Alternatives (ECOPA) unites national groups to advance the Three Rs (Replacement, Reduction, Refinement) in European research. ECOPA is a key stakeholder in scientific and political discussions on alternative methods.
Area of Science:
- * Animal research ethics
- * Toxicology and chemical safety
- * Scientific policy and regulation
Background:
- * ECOPA is an international non-profit organization promoting the Three Rs in Europe.
- * It is the sole quadripartite body representing animal welfare, industry, academia, and government.
- * ECOPA comprises 14 National Platforms across European member states.
Purpose of the Study:
- * To outline ECOPA's structure, mission, and stakeholder role.
- * To highlight ECOPA's engagement in EU research and chemical policy.
- * To emphasize ECOPA's contribution to educational programs on alternative methods.
Main Methods:
- * Collaboration through National Consensus Platforms.
- * Active participation in three working groups addressing key EU initiatives.
- * Dissemination of information via the ECOPA website.
Main Results:
- * ECOPA represents a broad consensus of stakeholders in alternative methods.
- * ECOPA actively influences EU policy on research and chemicals.
- * ECOPA provides expertise on scientific and political topics related to the Three Rs.
Conclusions:
- * ECOPA is a crucial stakeholder for the European Commission and Parliament.
- * ECOPA's unique position facilitates advancements in alternative methods.
- * ECOPA's work supports the ethical and scientific development of alternatives in Europe.
Related Concept Videos
01:19Restorative Care
Restorative care is provided once a patient has been discharged from a healthcare facility and requires additional services. The additional services include home care, rehabilitation programs, and extended care. Restorative care centers help the patient regain their previous level of functioning or acquire a new level of functioning due to the incapacitating effects of a disease or a disability. It aims to assist patients in enhancing their quality of life by encouraging independence,...
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:21Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD: